CARIBOU BIOSCIENCES INC (CRBU:NASDAQ)
$2.25 -0.04 (-1.7467%)
Analysed CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) News Sources
Discovering Whitehawk Therapeutics Among 3 Promising Penny Stocks
15-04-2026
yahoo.com
Three Best Genomics Stocks for Your Portfolio in 2026
13-04-2026
yahoo.com
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
02-04-2026
yahoo.com
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
31-03-2026
yahoo.com
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
26-03-2026
yahoo.com
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
16-03-2026
yahoo.com
Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference
14-03-2026
marketbeat.com
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
05-03-2026
yahoo.com
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
05-03-2026
yahoo.com
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
04-03-2026
yahoo.com
What is the current price of CARIBOU BIOSCIENCES INC (CRBU:NASDAQ)?
The current price of CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) is $2.25.
CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) since the previous trading day is $-0.04.
CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) since the previous trading day is -1.7467%.
What is the most recent average sentiment score for CARIBOU BIOSCIENCES INC (CRBU:NASDAQ)?
The most recent average sentiment score for CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for CARIBOU BIOSCIENCES INC (CRBU:NASDAQ)?
The most recent sentiment for CARIBOU BIOSCIENCES INC (CRBU:NASDAQ) is .
SEC-8K** Filing Available For CARIBOU BIOSCIENCES INC (CRBU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.